The longevity space has flourished. In the last decade a new clinical and cultural framework has emerged around the question of how to live longer and live better. Peter Attia has written the dominant textbook for the field, organized around cardiovascular risk, metabolic health, and what he calls the centenarian decathlon of physical capacities. Bryan Johnson has documented his own optimization in obsessive public detail and proven that the protocols are reproducible at a price. Casey Means and Mark Hyman have made metabolic dysfunction a household concern. Andrew Huberman has translated neurobiology into protocols that millions of people now follow. The framework is real, the audience is large, and the medicine, where it is good, is good.
Each of them has tried to address the brain. Each has done so as a chapter or a section rather than as the center of the work. Attia's chapter on cognition in Outlive is the thinnest part of the book — he is a cardiologist by training, and his discussion of brain health is appropriately humble: APOE testing, exercise, sleep, the gesture toward depression as a risk factor. Means and Hyman gesture similarly. Huberman addresses circuits and protocols but does not treat psychiatric illness. None of them has prescribed brexanolone for postpartum depression. None has managed a patient through the third failed antidepressant trial. None has sat with a family deciding whether to consent to electroconvulsive therapy. The brain chapter has been written, in each of their books, by clinicians whose primary expertise is not the brain.
This is not a criticism of their work. It is an observation about a gap. The longevity space was built by cardiologists, internists, and biohackers, who applied the rigor of their own disciplines to the questions they could see clearly. Their disciplines are not psychiatric. Their training did not include the years of clinical psychiatric exposure that produce the recognition patterns, the prescribing fluency, and the patient-encounter judgment that the brain chapter actually requires. The field that should have written the brain chapter is psychiatry. Psychiatry, for its part, has not yet shown up to write it.
The cost of this gap is visible in the clinical work of every primary care provider and every psychiatrist. The patient who has been told by his longevity-medicine clinic that his sleep needs work, but whose sleep apnea is undiagnosed because the longevity clinic does not order sleep studies. The patient who is optimizing her metabolic biomarkers while her depression accelerates her cognitive aging. The patient on three medications whose anticholinergic burden is dropping his memory function, prescribed by clinicians who do not think about anticholinergic burden because anticholinergic burden is a psychiatric concept. The longevity industry is delivering excellent metabolic and cardiovascular care alongside thin and sometimes counterproductive brain care.
Patients sense the gap. The forty-five-year-old who is doing everything right metabolically and has read every Attia podcast still asks her primary care doctor whether her mother's Alzheimer's means she should be worried. The answer she receives — you're doing everything right, keep doing what you're doing — is well-intentioned and incomplete. There are things she should be doing that she is not doing. Hearing assessment and treatment if needed. Sleep apnea evaluation. Inflammation panel. Hormonal assessment as she enters perimenopause. Cognitive baseline testing. An honest conversation about depression and its under-recognized neurodegenerative implications. None of these is in the standard longevity-medicine protocol because the standard longevity-medicine protocol was written without psychiatric input.
The clinicians who do this work — psychiatrists, neuropsychiatrists, PMHNPs with longevity-aware practices — are working without a canon. There is no Stahl for longevity psychiatry. There is no Attia of the brain. There is no centerpiece volume that integrates the lifestyle prevention literature, the refractory psychiatric treatment landscape, the neurosteroid and psychedelic frontier, the optimization literature, the dementia care reality, and the end-stage practice into a single coherent framework. The work of writing that canon, and of defining the field that uses it, is the work of this volume.
Every field begins this way. Cardiology was once a chapter inside internal medicine. Geriatrics was once a curiosity. Psychiatry itself was, for centuries, not a medical specialty. The fields that mattered have always emerged from a clinical reality that was visible to the clinicians inside it but invisible to the surrounding medical establishment. The clinical reality this volume names is visible to anyone who treats psychiatric patients across a lifespan: that the brain is the longevity question, that no field is currently doing the work, and that the work is overdue.